Use of intravenous immunoglobulin in chronic lymphocytic leukemia. A brief review.
Chronic lymphocytic leukemia (CLL) is a disorder with multiple defects leading to an increased susceptibility to infection. Hypogammaglobulinemia is present in about 20% to 70% of patients with CLL. Intravenous immunoglobulin (IVIG) supplementation (400 mg/kg body weight every 3 weeks) prevented bac...
| Những tác giả chính: | , , , , , , , , |
|---|---|
| Định dạng: | Conference item |
| Được phát hành: |
1991
|